The Health Service Executive (HSE) has approved BIMZELEX (bimekizumab) in Ireland for adults living with moderate-to-severe ...
The HS market in the 7MM offers growth through innovative biologics and small molecules by 2034, driven by key pipeline agents like sonelokimab and povorcitnib. Opportunities include in-licensing, new ...
Obesity, diabetes, and other comorbidities increase GLP-1 agonist prescriptions in hidradenitis suppurativa. Learn more.
Vietnam Investment Review on MSN
Dimora Medical Supports HS Connect Empower Workshop to Promote Science-Based Care for Hidradenitis Suppurativa Patients
Patient-centered nonprofit organization HS Connect recently hosted the Empower HS: Knowledge and Advocacy Workshop, an ...
Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Adding intense pulsed light (IPL) and radiofrequency irradiation to standard treatment significantly enhances skin improvement in patients with hidradenitis suppurativa, making the ...
People with hidradenitis suppurativa (HS) sometimes receive misdiagnosis for other conditions, including folliculitis and acne. A dermatologist can make an accurate diagnosis. Hidradenitis suppurativa ...
New research reveals that switching from originator to biosimilar adalimumab for hidradenitis suppurativa may lead to reduced ...
While glucocorticoids are generally effective as first-line treatment in IgG4-RS, this is not the case in primary Sjögren's syndrome, making it imperative that the 2 conditions, although similar, are ...
Introduction: BCG vaccination is currently recommended for all newborns in Ireland except where specifically contraindicated. This paper describes a marked increase in the number of referrals of ...
23 Istituto Giannina Gaslini, Pediatria II, Reumatologia and Universià degli Studi di Genova, Genova, Italy 24 Istituto Giannina Gaslini, Pediatria II, Reumatologia, Genova, Italy Correspondence to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results